IGF2 and memory impairment: Another study revealed that neonatal administration of thyroxine and metformin in patients with FASD improved memory impairment via elevating DNMT1 and consequently normalizing hippocampal deiodinase-III (Dio3) and insulin-like growth factor 2 (Igf2) expressions in the adult offspring [143].